Invention Grant
US07807146B2 Methods for treating cancer with a recombinant MVA expressing HER-2
有权
用表达HER-2的重组MVA治疗癌症的方法
- Patent Title: Methods for treating cancer with a recombinant MVA expressing HER-2
- Patent Title (中): 用表达HER-2的重组MVA治疗癌症的方法
-
Application No.: US11905876Application Date: 2007-10-05
-
Publication No.: US07807146B2Publication Date: 2010-10-05
- Inventor: Alain Delcayre , Reiner Laus , Stefanie Mandl
- Applicant: Alain Delcayre , Reiner Laus , Stefanie Mandl
- Applicant Address: US CA Mountain View
- Assignee: BN Immunotherapeutics, Inc.
- Current Assignee: BN Immunotherapeutics, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Law Office of Salvatore Arrigo
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K48/00 ; A01N43/04
Abstract:
The invention relates to compositions, kits, and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated antigen, such as HER-2, particularly in combination with taxanes. The taxanes can be administered prior to, at the same time as, or after the recombinant MVA virus.
Public/Granted literature
- US20080213302A1 Methods for treating cancer with MVA Public/Granted day:2008-09-04
Information query
